Products & ReviewLife Sciences

Enhanced Liver Fibrosis (ELF™) Test

Siemens Healthineers offers the ELF test to help improve the assessment of NAFLD/NASH and chronic liver disease patients at risk of disease progression.

Request Pricing
Siemens Healthineers

Receive your quote directly from the manufacturer.

Ease of Use
After Sales Service
Value for Money
Write your own review

The ELF Test* is a non-invasive blood test that measures three direct markers of fibrosis: hyaluronic acid (HA), procollagen III amino-terminal peptide (PIIINP), and tissue inhibitor of matrix metalloproteinase 1 (TIMP-1). The ELF Test, in conjunction with other laboratory and clinical findings, can be used to assess the risk of progression to cirrhosis and liver-related clinical events (LREs) in patients with chronic liver disease.

  • Access non-invasive testing with a simple blood test available to all healthcare practitioners and patients, including those with type 2 diabetes mellitus and obesity.
  • Improve patient care by identifying non-alcoholic fatty liver disease (NAFLD) patients and stratifying those at risk of progressing to cirrhosis and LREs.
  • Enhance prognostic patient management with a test that has been shown to outperform biopsy for the risk assessment of progression to cirrhosis and LREs.

*The ELF Test kit is under development in the U.S. Product availability varies by country.The ELF Testing Service is available from Siemens Healthcare Laboratory, a CLIA-certified laboratory located in Berkeley, CA.

Product Overview